^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    APVAC1 vaccine

    i
    Associations
    News

    Trials

    Company:
    BioNTech, Immatics
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients (NCT02149225)
    Phase 1
    Immatics Biotechnologies GmbH
    Completed
    Last update posted :
    08/07/2018
    Initiation :
    10/01/2014
    Primary completion :
    06/01/2018
    Completion :
    06/01/2018
    HLA-A • CSF2
    |
    HLA-A*02 • HLA-A*24
    |
    temozolomide • APVAC1 vaccine • Hiltonol (poly-ICLC) • Leukine (sargramostim)